3-Aminopicolinate inhibits phosphoenolpyruvate carboxykinase in hepatocytes and increases release of gluconeogenic precursors from peripheral tissues.

doi:10.1016/s0021-9258(17)39815-0

Paper

3-Aminopicolinate inhibits phosphoenolpyruvate carboxykinase in hepatocytes and increases release of gluconeogenic precursors from peripheral tissues.

Published Jun 10, 1984 · K. Chen, H. Lardy

The Journal of biological chemistry

Q1 SJR score

6

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

3-Aminopicolinate increases blood glucose levels by inhibiting phosphoenolpyruvate carboxykinase in hepatocytes and increasing gluconeogenic substrate supply from peripheral tissues.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

3-Aminopicolinate inhibits phosphoenolpyruvate carboxykinase in hepatocytes and increases release of gluconeogenic precursors from peripheral tissues.

References

Citations